Comparison Taysha Gene Therapies (TSHA) with Competitors
Taysha Gene Therapies (TSHA) industry is Biotechnology.
Operating Margin
TSHA-1774.00%
Industry-2073.25%
Upside+299.25%
Debt-to-Equity
TSHA23.10%
Industry29.76%
Upside-22.37%
Free Cash Flow Yield
TSHA-6.82%
Industry-1.94%
Upside-4.88%
P/E
TSHA-12.41
Industry-18.88
Upside+647.01%
P/S
TSHA225.78
Industry9.28
Upside+2332.40%
P/B
TSHA8.00
Industry4.70
Upside+70.30%